Anti-proliferative lichen compounds with inhibitory activity on 12(S)-HETE production in human platelets

Phytomedicine

Volumn 11, Issue 7-8, 2004, Pages 602-606

  Bucar, F ^a   Schneider, I ^a   Ogmundsdottir H ^b   Ingolfsdottir K ^c  

^a UNIVERSITY OF GRAZ   (Austria)

^b ICELANDIC CANCER SOCIETY   (Iceland)

^c UNIVERSITY OF ICELAND   (Iceland)

Author keywords

12(S) HETE; 12 lipoxygenase; Baeomycesic acid; Lichen; Lobaric acid; Parietin; Protolichesterinic acid; Usnic acid

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ANTHRAQUINONE DERIVATIVE; ANTITHROMBOCYTIC AGENT; ARACHIDONATE 12 LIPOXYGENASE; BAEOMYCESIC ACID; BAICALEIN; CARBENOID; DIBENZOFURAN DERIVATIVE; FLAVONE DERIVATIVE; GAMMA LACTONE DERIVATIVE; LIPOXYGENASE INHIBITOR; LOBARIC ACID; NATURAL PRODUCT; ORCINOL; PHYSCION; PROTOLICHESTERINIC ACID; UNCLASSIFIED DRUG; USNIC ACID;

ARTICLE; CELL PROLIFERATION; CLADONIA ARBUSCULA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ISOLATION; DRUG SELECTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LICHEN ISLANDICUS; LICHENS; NONHUMAN; PRIORITY JOURNAL; STEREOCAULON ALPINUM; THAMNOLIA VERMICULARIS SUBULIFORMIS; THROMBOCYTE; XANTHORIA ELEGANS;

CETRARIA ISLANDICA; CLADONIA ARBUSCULA; CLADONIACEAE; PARMELIACEAE; STEREOCAULON; STEREOCAULON ALPINUM; THAMNOLIA VERMICULARIS; XANTHORIA ELEGANS;

EID: 9744278459     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2004.03.004     Document Type: Article

References (20)

1. Ding, X.Z., Hennig, R., Adrian, T.E., 2003. Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer. Mol Cancer 2, 10-21.
2. Ingólfsdóttir, K., Breu, W., Huneck, S., Gudjónsdóttir, G.A., Müller-Jakic, B., Wagner, H., 1994. In vitro inhibition of 5-lipoxygenase by protolichesterinic acid from Cetraria islandica. Phytomedicine 1, 187-191.
3. Ingólfsdóttir, K., Gissurarson, S.R., Müller-Jakic, B., Breu, W., Wagner, H., 1996. Inhibitory effects of the lichen metabolite lobaric acid on arachidonate metabolism in vitro. Phytomedicine 2, 243-246.
4. Ingólfsdóttir, K., Birgisdóttir, M., Wiedermann, B., Nenninger, A., Jónsdóttir, S., Wagner, H., 1997. Inhibitory effects of baeomycesic acid from Thamnolia subuliformis on arachidonate metabolism. Phytomedicine 4, 125-128.
5. Ingólfsdóttir, K., Chung, G.A.C., Gissurarson, S.R., Skulason, V.G., Vilhelmsdóttir, M., 1998. In vitro antimycobacterial activity of lichen metabolites. Eur J Pharm Sci 6, 141-144.
6. Kristmundsdóttir, T., Aradóttir, H.A.E., Ingólfsdóttir, K., Ögmundsdóttir, H.M., 2002. Solubilization of the lichen metabolite (+)-usnic acid for testing in tissue culture. J Pharm Pharmacol 54, 1447-1452.
7. Natarajan, R., Nadler, J., 1998. Role of lipoxygenases in breast cancer. Front Biosci 3, 81-88.
8. Nie, D., Che, M., Grignon, D., Tang, K., Honn, K.V., 2001. Role of eicosanoids in prostate cancer progression. Cancer Metast Rev 20, 195-206.
9. Nie, D., Honn, K.V., 2002. Cyclooxygenase, lipoxygenase and tumor angiogenesis. Cell Mol Life Sci 59, 799-807.
10. Ögmundsdóttir, H.M., Zoëga, G.M., Gissurarson, S.R., Ingólfsdóttir, K., 1998. Anti-proliferative effects of lichen-derived inhibitors of 5-lipoxygenase on malignant cell lines and mitogen-stimulated lymphocytes. J Pharm Pharmacol 50, 107-115.
11. Paulson, A. S., Kristinsson, H., Ingólfsdóttir, K., 2004. Unpublished results
12. β5 integrin expression. Cancer Res 63, 4258-4267.
13. Schneider, I., Gibbons, S., Bucar, F., 2004. Inhibitory activity of Juniperus communis on 12(S)-HETE production in human platelets. Planta Med 70, 471-474.
14. Sekiya, K., Okuda, H., 1982. Selective inhibition of platelet lipoxygenase by baicalein. Biochem Biophys Res Commun 105, 1090-1095.
15. Shureiqi, I., Lippman, S., 2001. Lipoxygenase modulation to reverse carcinogenesis. Cancer Res 61, 6307-6312.
16. Timar, J., Raso, E., Dome, B., Li, L., Grignon, D., Nie, D., Honn, K.V., Hagmann, W., 2000. Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential. Int J Cancer 87, 37-43.
17. Tong, W-G., Ding, X-Z., Witt, R.C., Adrian, T.E., 2002. Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol Cancer Ther 1, 929-935.
18. Virmani, J., Johnson, E.N., Klein-Szanto, A.J.P., Funk, C.D., 2001. Role of platelet-type 12-lipoxygenase in skin carcinogenesis. Cancer Lett 162, 161-165.
19. Yamamoto, S., Suzuki, H., Ueda, N., 1997. Arachidonate 12-lipoxygenases. Prog Lipid Res 36, 23-41.
20. Yoshimoto, T., Takahashi, Y., 2002. Arachidonate 12-lipoxygenases. Prostagl Other Lipid Mediators 68-69, 245-262.